Sangamo Therapeutics
SGMO
#8265
Rank
โ‚ฌ0.16 B
Marketcap
0,72ย โ‚ฌ
Share price
8.06%
Change (1 day)
56.18%
Change (1 year)

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2024 (TTM): โ‚ฌ52.27 Million

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ50.73 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ55.54 M-65.16%
2023 โ‚ฌ0.15 B53.64%
2022 โ‚ฌ0.10 B6.15%
2021 โ‚ฌ97.74 M1.72%
2020 โ‚ฌ96.09 M5.09%
2019 โ‚ฌ91.43 M23.86%
2018 โ‚ฌ73.82 M142.23%
2017 โ‚ฌ30.47 M65.33%
2016 โ‚ฌ18.43 M-49.03%
2015 โ‚ฌ36.16 M-4.12%
2014 โ‚ฌ37.71 M115.83%
2013 โ‚ฌ17.47 M6.74%
2012 โ‚ฌ16.37 M106.03%
2011 โ‚ฌ7.94 M-49.2%
2010 โ‚ฌ15.64 M1%
2009 โ‚ฌ15.48 M33.75%
2008 โ‚ฌ11.57 M85.81%
2007 โ‚ฌ6.23 M4.27%
2006 โ‚ฌ5.97 M185.09%
2005 โ‚ฌ2.09 M116.22%
2004 โ‚ฌ0.96 M-52.68%
2003 โ‚ฌ2.04 M-50.69%
2002 โ‚ฌ4.15 M-24.89%
2001 โ‚ฌ5.53 M51.79%
2000 โ‚ฌ3.64 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ25.23 B 49,645.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.97 B 3,789.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.33 B 57,726.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ8.49 B 16,640.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.70 B 74,232.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ77.95 B 153,569.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.50 B 4,837.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.32 B 110,917.30%๐Ÿ‡บ๐Ÿ‡ธ USA